Upload Avatar (500 x 500)
Fang Liu
Psychiatry
Wenzhou Medical University
Zhejiang
Language: English, Chinese
Mental Disorders
Molecular Mechanisms
Treatment
Biomarkers
Drug Development
Clinical Research
Translational Research
Schizophrenia
Depression
Neuroscience
Areas of Focus
- Molecular mechanisms and treatment of mental disorders
Work Experience
- 2020 - University of Toronto - Tapscott Chair in Schizophrenia Studies
Academic Background & Achievements
- Doctorate: Not mentioned
- Elected Fellow of the Canadian Academy of Health Sciences (2019)
- Published nearly 100 academic papers in journals like Nature, Cell, Neuron, Nature Medicine
- H-index of 64
- Led over 20 Canadian national research projects
- Granted 8 international patents
Publications
- The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder., Li H, Su P, Lai TK, Jiang A, Liu J, Zhai D, Campbell CT, Lee FH, Yong W, Pasricha S, Li S, Wong AH, Ressler KJ, Liu F., 2020
- The Eph receptor A4 plays a role in demyelination and depression-related behavior., Li Y, Su P, Chen Y, Nie J, Yuan TF, Wong AH, Liu F., 2022
- Disruption of SynGAP-dopamine D1 receptor complexes alters actin and microtubule dynamics and impairs GABAergic interneuron migration., Su P, Lai TKY, Lee FHF, Abela AR, Fletcher PJ, Liu F., 2019
- Specific Alterations in Astrocyte Properties via the GluA2-GAPDH Complex Associated with Multiple Sclerosis., Lee FHF, Zhang H, Jiang A, Zai CC, Liu F., 2018
Awards
- Canadian Cardiovascular Foundation Research Award
- American Schizophrenia and Depression Research Association Award
